These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10518316)

  • 1. Biological responses of dog prostate and adjacent structures after meso-tetra-(m-hydroxyphenyl) chlorin and aluminum disulfonated phthalocyanine based photodynamic therapy.
    Chang SC; Chern IF; Hsu YH
    Proc Natl Sci Counc Repub China B; 1999 Oct; 23(4):158-66. PubMed ID: 10518316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin.
    Chang SC; Buonaccorsi G; MacRobert A; Bown SG
    Int J Cancer; 1996 Aug; 67(4):555-62. PubMed ID: 8759616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX.
    Chang SC; Buonaccorsi GA; MacRobert AJ; Bown SG
    Prostate; 1997 Jul; 32(2):89-98. PubMed ID: 9215396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
    Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
    Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
    Moore CM; Nathan TR; Lees WR; Mosse CA; Freeman A; Emberton M; Bown SG
    Lasers Surg Med; 2006 Jun; 38(5):356-63. PubMed ID: 16392142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy for cancer of the upper aerodigestive tract using tetra(m-hydroxyphenyl)chlorin.
    Grosjean P; Savary JF; Mizeret J; Wagnieres G; Woodtli A; Theumann JF; Fontolliet C; Van den Bergh H; Monnier P
    J Clin Laser Med Surg; 1996 Oct; 14(5):281-7. PubMed ID: 9612194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental evaluation of possible side effects of intra-operative photodynamic therapy on rabbit blood vessels and nerves.
    Kübler AC; Stenzel W; Rühling M; Meul B; Fischer JH
    Lasers Surg Med; 2003; 33(4):247-55. PubMed ID: 14571449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers.
    Chen Q; Huang Z; Luck D; Beckers J; Brun PH; Wilson BC; Scherz A; Salomon Y; Hetzel FW
    Photochem Photobiol; 2002 Oct; 76(4):438-45. PubMed ID: 12405153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular effects of the liposomal mTHPC derivative Foslipos in prostate carcinoma cells in vitro.
    Gyenge EB; Hiestand S; Graefe S; Walt H; Maake C
    Photodiagnosis Photodyn Ther; 2011 Jun; 8(2):86-96. PubMed ID: 21497299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the TAT-RasGAP(317-326) peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light.
    Pittet O; Petermann D; Michod D; Krueger T; Cheng C; Ris HB; Widmann C
    J Photochem Photobiol B; 2007 Jul; 88(1):29-35. PubMed ID: 17560792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin.
    Mitra S; Foster TH
    Photochem Photobiol; 2005; 81(4):849-59. PubMed ID: 15807635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of photodynamic therapy mediated by nanoemulsion containing chloro-aluminum phthalocyanine: a histologic and immunohistochemical study in human gingiva.
    de Moraes M; de Vasconcelos RC; Longo JP; Muehlmann LA; de Azevedo RB; Lemos TM; Costa Ade L
    Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):592-7. PubMed ID: 26521145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative sensitivity of microvascular endothelial cells, fibroblasts and tumor cells after in vitro photodynamic therapy with meso-tetra-hydroxyphenyl-chlorin.
    Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
    Photochem Photobiol; 2004; 80(2):236-41. PubMed ID: 15362947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy.
    Glanzmann T; Hadjur C; Zellweger M; Grosiean P; Forrer M; Ballini JP; Monnier P; van den Bergh H; Lim CK; Wagnières G
    Photochem Photobiol; 1998 May; 67(5):596-602. PubMed ID: 9613244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue levels, histologic changes and plasma pharmacokinetics of meta-Tetra (hydroxyphenyl) chlorin (mTHPC) in the cat.
    Campbell GA; Bartels KE; Arnold C; Healey T; Cowell RL; Lucroy MD; Ronn AM
    Lasers Med Sci; 2002; 17(2):79-85. PubMed ID: 12111590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
    Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
    Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers.
    Ma L; Moan J; Berg K
    Int J Cancer; 1994 Jun; 57(6):883-8. PubMed ID: 8206681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy in the canine prostate using motexafin lutetium.
    Hsi RA; Kapatkin A; Strandberg J; Zhu T; Vulcan T; Solonenko M; Rodriguez C; Chang J; Saunders M; Mason N; Hahn S
    Clin Cancer Res; 2001 Mar; 7(3):651-60. PubMed ID: 11297261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of the cutaneous phototoxicity of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin.
    Wagnieres G; Hadjur C; Grosjean P; Braichotte D; Savary JF; Monnier P; van den Bergh H
    Photochem Photobiol; 1998 Sep; 68(3):382-7. PubMed ID: 9747593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.